Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Cara De Galan

Awards & Distinctions

10 Results

2022

New insights in the use of vedolizumab in inflammatory bowel disease

Cara De GalanDebby LaukensPieter Hindryckx

Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study

Cara De GalanBryan GonzalesSophie Van WeldenSimon TavernierTriana Lobatón OrtegaWouter Van MoerkerckeBeatrijs StrubbeHarald PeetersElisabeth MackenMartine De Vos et al.

A1 Journal Article in CLINICAL AND TRANSLATIONAL MEDICINE

The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study

Cara De GalanMarie TruyensHarald PeetersFrancisco Mesonero GismeroAinara ElorzaPaola TorresLiv VandermeulenAranzazu Jauregui AmezagaRocio Ferreiro- IglesiasTom Holvoet et al.

A1 Journal Article in JOURNAL OF CROHNS & COLITIS

2021

Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study

Cara De GalanGerard Bryan GonzalesSophie Van WeldenSimon TavernierTriana Lobatón OrtegaWouter Van MoerkerckeBeatrijs StrubbeHarald PeetersElisabeth MackenMartine De Vos et al.

Long-term environmental hypoxia does not impact experimental Crohn's like ileitis

Cara De GalanSophie Van WeldenTriana Lobatón OrtegaPieter HindryckxMartine De VosDebby Laukens

Long-term environmental hypoxia exposure and haematopoietic prolyl hydroxylase-1 deletion do not impact experimental Crohn's like ileitis

Cara De GalanMartine De VosPieter HindryckxDebby LaukensSophie Van Welden

A1 Journal Article in BIOLOGY-BASEL

Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study

Cara De GalanMarie TruyensHarald PeetersFrancisco Mesonero GismeroAinara ElorzaPaola TorresLiv VandermeulenAranzazu Jauregui AmezagaRocio Ferreiro-IglesiasTom Holvoet et al.

The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study

Marie TruyensCara De GalanH PeetersF Mesonero GismeroA ElorzaP TorresL VandermeulenA Jauregui AmezagaR Ferreiro-IglesiasT Holvoet et al.

2020

Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De GalanSophie Van WeldenSimon BosSimon TavernierTriana Lobatón OrtegaBryan GonzalesWouter Van MoerkerckeBeatrijs StrubbeHarald PeetersElisabeth Macken et al.

2019

Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De GalanSophie Van WeldenSimon BosSimon TavernierTriana Lobatón OrtegaBryan GonzalesWouter Van MoerkerckeBeatrijs StrubbeHarald PeetersElisabeth Macken et al.